Richard shares the challenges of managing a flood of emails and competing priorities in venture capital. He emphasizes the importance of balancing urgent tasks with long-term projects, like writing white papers on emerging therapeutics. The discussion also highlights the need for a broad understanding of scientific topics while evaluating potential investments, showcasing the unique skill set required in this fast-paced industry.
